Y
Yifeng Xu
Researcher at Shanghai Jiao Tong University
Publications - 143
Citations - 4940
Yifeng Xu is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Schizophrenia & Single-nucleotide polymorphism. The author has an hindex of 24, co-authored 129 publications receiving 3339 citations. Previous affiliations of Yifeng Xu include Brigham and Women's Hospital & Shanghai Mental Health Center.
Papers
More filters
Journal ArticleDOI
Prevalence of mental disorders in China: a cross-sectional epidemiological study.
Yueqin Huang,Yu Wang,Hong Wang,Zhaorui Liu,Xin Yu,Jie Yan,Yaqin Yu,Changgui Kou,Xiufeng Xu,Jin Lu,Zhizhong Wang,Shulan He,Yifeng Xu,Yanling He,Tao Li,Wanjun Guo,Hongjun Tian,Guangming Xu,Xiangdong Xu,Yanjuan Ma,Linhong Wang,Limin Wang,Yongping Yan,Bo Wang,Shuiyuan Xiao,Liang Zhou,Lingjiang Li,Liwen Tan,Tingting Zhang,Chao Ma,Qiang Li,Hua Ding,Hongchun Geng,Fu-Jun Jia,Jianfei Shi,Shiliang Wang,Ning Zhang,Xinbai Du,Xiangdong Du,Yue Wu +39 more
TL;DR: The evidence from this survey poses serious challenges related to the high burdens of disease identified, but also offers valuable opportunities for policy makers and health-care professionals to explore and address the factors that affect mental health in China.
Journal ArticleDOI
Patients with mental health disorders in the COVID-19 epidemic.
Hao Yao,Jian-Hua Chen,Yifeng Xu +2 more
Journal ArticleDOI
Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia.
Zhiqiang Li,Jianhua Chen,Hao Yu,Hao Yu,Hao Yu,Lin He,Yifeng Xu,Dai Zhang,Dai Zhang,Dai Zhang,Qizhong Yi,Changgui Li,Xingwang Li,Jiawei Shen,Zhijian Song,Weidong Ji,Meng Wang,Juan Zhou,Boyu Chen,Yahui Liu,Jiqiang Wang,Peng Wang,Ping Yang,Qingzhong Wang,Guoyin Feng,Benxiu Liu,Wensheng Sun,Baojie Li,Guang He,Weidong Li,Chunling Wan,Qi Xu,Wenjin Li,Zujia Wen,Ke Liu,Fang Huang,Jue Ji,Stephan Ripke,Stephan Ripke,Stephan Ripke,Weihua Yue,Weihua Yue,Patrick F. Sullivan,Patrick F. Sullivan,Michael Conlon O'Donovan,Yongyong Shi +45 more
TL;DR: The genome-wide association study with replication in 36,180 Chinese individuals and transancestry meta-analyses with data from the Psychiatry Genomics Consortium provide novel insight into the genetic architecture and biological etiology of schizophrenia.
Journal ArticleDOI
Common variants on 8p12 and 1q24.2 confer risk of schizophrenia
Yongyong Shi,Zhiqiang Li,Qi Xu,Ti Wang,Tao Li,Jiawei Shen,Fengyu Zhang,Jianhua Chen,Guoquan Zhou,Weidong Ji,Baojie Li,Yifeng Xu,Dengtang Liu,Peng Wang,Ping Yang,Benxiu Liu,Wensheng Sun,Chunling Wan,Shengying Qin,Guang He,Stacy Steinberg,Sven Cichon,Thomas Werge,Engilbert Sigurdsson,Sarah Tosato,Aarno Palotie,Markus M. Nöthen,Marcella Rietschel,Marcella Rietschel,Roel A. Ophoff,Roel A. Ophoff,David A. Collier,Dan Rujescu,David St Clair,Hreinn Stefansson,Kari Stefansson,Jue Ji,Qingzhong Wang,Wenjin Li,Linqing Zheng,Hairong Zhang,Guoyin Feng,Lin He +42 more
TL;DR: Zhang et al. as discussed by the authors performed a genome-wide association study (GWAS) in the Han Chinese population to identify new common genetic risk factors, and found common SNPs that associated with schizophrenia with genomewide significance on 8p12 (rs16887244, P = 1.27 × 10(-10)) and 1q24.2 (rs10489202, p = 9.50 × 10−9)).
Journal ArticleDOI
Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study
Jin Lu,Xiufeng Xu,Yueqin Huang,Tao Li,Chao Ma,Guangming Xu,Huifang Yin,Xiangdong Xu,Yanjuan Ma,Limin Wang,Zhengjing Huang,Yongping Yan,Bo Wang,Shuiyuan Xiao,Liang Zhou,Lingjiang Li,Yan Zhang,Hongguang Chen,Tingting Zhang,Jie Yan,Hua Ding,Yaqin Yu,Changgui Kou,Zonglin Shen,Linling Jiang,Linling Jiang,Zhizhong Wang,Xian Sun,Yifeng Xu,Yanling He,Wanjun Guo,Lijun Jiang,Lijun Jiang,Shengyan Li,Wen Pan,Yue Wu,Guohua Li,Fu-Jun Jia,Jianfei Shi,Zhongxia Shen,Ning Zhang +40 more
TL;DR: Wang et al. as discussed by the authors used the Composite International Diagnostic Interview 3.0 to ascertain the presence of lifetime and 12-month depressive disorders according to DSM-IV criteria, including major depressive disorder, dysthymic disorder and depressive disorder not otherwise specified.